“Ascend Wellness Holdings is poised to report its Q4 2025 results on March 12, 2026, with preliminary guidance pointing to approximately $120 million in net revenue and $30 million in Adjusted EBITDA, reflecting a 25% margin amid ongoing industry pressures. Despite a sequential revenue dip from Q3’s $124.7 million and a year-over-year decline, the company … Read more
“In its latest earnings discussion, Boralex showcased an 18% quarterly production surge driven by favorable wind conditions and new project commissions, yet full-year results fell short of expectations due to lower-than-anticipated resource levels and weaker short-term power prices in France. Combined EBITDA rose in Q4 but declined slightly annually, while net earnings improved sharply in … Read more
“Clover Health reported Q4 2025 total revenues of approximately $488 million, marking a roughly 45% year-over-year increase and surpassing analyst expectations. The company posted a GAAP net loss but achieved full-year Adjusted EBITDA profitability of $22 million for 2025, with Medicare Advantage membership climbing 38% to over 113,000. Despite ongoing industry cost pressures, medical trends … Read more